The VeriSeq™ NIPT solution from Illumina is a powerful screening test that provides the most comprehensive view of the fetal genome using a simple maternal blood draw. Cell-free DNA, released by placental cells during pregnancy, can be used to test for selected chromosomal abnormalities in the fetus as early as 10 weeks’ gestation. Find out how this NIPT workflow provides aneuploidy screening in three simple steps. #Illumina #NIPTScreening #VeriSeq